COURELI
Live / Applied — Non-final action mailed (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 15 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79437682
- Mark type
- Stylized text
- Filed
- 15 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.
Owner
- Novo Nordisk A/S, DK
Prosecution history
- 01 Apr 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 01 Apr 2026 — REFUSAL PROCESSED BY MPU
- 04 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 03 Mar 2026 — NON-FINAL ACTION WRITTEN
- 03 Mar 2026 — ASSIGNED TO EXAMINER
- 04 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB